Maulin Group Acquires THEMIS Clinical Defence

January 6, 2026

Maulin Group has acquired THEMIS Clinical Defence, a regulated medical-indemnity provider, and will integrate it into Maulin's clinical-risk intelligence ecosystem while preserving THEMIS's operational independence. The deal is intended to accelerate THEMIS's UK consolidation and rapid international expansion by leveraging Maulin's risk intelligence, legal, technology and operational capabilities.

Buyers
Maulin Group
Targets
THEMIS Clinical Defence
Location
Kent, United Kingdom
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.